MedTrace Logo

New Methods of Distribution of a Self Sampler Kit for Cervical Cancer Screening

NCT01647724 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15000

Last updated 2012-07-24

No results posted yet for this study

Summary

The opportunity of a home, self-collected sample, opens the chance to remove some of the barriers that may discourage women from participating to screening programmes or performing HPV (Human Papilloma Virus)-test. Self-sampling is less time consuming and invasive as compared with tests performed at a clinic. It allows for privacy, reduces discomfort and women know nobody would have to handle their body.

Study hypothesis: The use of a self-sampler may increase the recovery of non-responders women at cervical cancer screening.

Conditions

  • Cervical Cancer Cin Grade

Sponsors & Collaborators

  • Azienda Sanitaria Locale 4, Teramo

    lead OTHER

Principal Investigators

  • Emma Altobelli, Prof. · AUSL4 Teramo - Italy

Eligibility

Min Age
35 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-12-31
Completion
2013-03-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01647724 on ClinicalTrials.gov